which some may pose significant ethical and logistical challenges. This study aimed to canvas such views and establish future research directions in this space.
AUDIT OF ALBUMIN TRANSFUSION USE IN THE NEONATAL INTENSIVE CARE UNIT (NICU)
Wong G 1 , Smirk C 1 Royal Children's Hospital, Melbourne, Australia Email: cam.smirk@rch.org.au
Background: Hypotonic (4%) and hypertonic (20%) albumin transfusions are used frequently in the NICU setting despite a lack of evidence and potential adverse effects. The aim of this audit was to define and evaluate the use of albumin transfusions in a population of surgical neonatal patients admitted to the Royal Children's Hospital (RCH) NICU.
Methods: Data was sourced from the Electronic Medical Record (EMR) of RCH NICU patients admitted between January -March 2018, requiring a surgical procedure. Data pertaining to demographics, types of surgery and albumin transfusions were analysed.
Results: Overall, 61 patients (gestational age range 23-41 weeks) and 96 procedures were audited. 52% of patients received post-operative albumin. Both 4% and 20% albumin solutions were used to manage both post-operative volume depletion and hypoalbuminaemia. 13% of post-operative albumin transfusions (n = 124) did not have a reason for transfusion listed in EMR. Patients who received post-operative albumin were more likely to have undergone more surgical procedures than those who did not (p = 0.01). Overall, we did not identify any patient factors that were consistently associated with the use of albumin transfusions.
Conclusions: Albumin transfusion use is widespread in the RCH NICU and the type of solution used to manage different post-operative issues is inconsistent. Further research into albumin transfusions and clinical outcomes in NICU patients is required for the future development of clinical guidelines. The most common form of overdose in pregnancy is with paracetamol. Both paracetamol and its antidote, Nacetylcysteine, cross the placenta, and therefore may affect the fetus. The aim of this report is to present a case of maternal paracetamol overdose, demonstrating favourable maternal and fetal outcome with timely initiation of NAC infusion, and to review existing literature regarding maternal-fetal outcomes after antenatal paracetamol overdose and safety of N-acetylcysteine infusion in pregnancy.
Methods: A literature review was performed using the terms "acetaminophen", "paracetamol", "overdose", and "pregnancy" on the PubMed database, on the 12th October 2018.
Results: 29 relevant articles were identified from the search, of which 16 were individual case reports, 6 were population studies, and 7 were review articles. A total of 388 cases of paracetamol intoxication in pregnancies were identified. Excluding cases in the first trimester of pregnancy and elective termination of pregnancy, the rate of adverse events was 13% (35 out of 232 cases) and includes antenatal complications, congenital abnormalities or organ dysfunction and fetal demise.
Conclusions: There is currently limited data reporting on the pregnancy outcomes following maternal paracetamol toxicity. Although the safety of N-acetylcysteine use in pregnancy remains unclear, prompt treatment in cases of suspected maternal paracetamol overdose is recommended. Background: Neurovascular coupling (NVC) leads to increased local cerebral blood flow and oxygenation to meet the increased metabolic demand of neural activity. Immature NVC in the preterm newborn may predispose the brain to cerebral hypoxia when neural activity is increased. We reported that prolonged somatosensory stimulation in fetal sheep reduced cerebral oxygenation (negative cerebral haemodynamic response) (Nakamura et al. 2017) . We now characterise the cerebral haemodynamic response after somatosensory stimulation in the preterm newborn lamb, by measuring changes in cerebral oxy-and deoxy-haemoglobin (ΔoxyHb, ΔdeoxyHb) using near infrared spectroscopy (NIRS).
CEREBRAL HAEMODYNAMIC FUNCTIONAL RESPONSE TO SOMATOSENSORY STIMULATION IN PRETERM LAMBS

